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2001.—The role of ATP-sensitive K1 (KATP
1 ) channels in
vasomotor tone regulation during metabolic stimulation is
incompletely understood. Consequently, we studied the con-
tribution of KATP
1 channels to vasomotor tone regulation in
the systemic, pulmonary, and coronary vascular bed in nine
treadmill-exercising swine. Exercise up to 85% of maximum
heart rate increased body O2 consumption fourfold, accom-
modated by a doubling of both cardiac output and body O2
extraction. Mean aortic pressure was unchanged, implying
that systemic vascular conductance (SVC) also doubled,
whereas pulmonary artery pressure increased almost in par-
allel with cardiac output, so that pulmonary vascular con-
ductance (PVC) increased only 25 6 9% (both P , 0.05).
Myocardial O2 consumption tripled during exercise, which
was paralleled by an equivalent increase in O2 supply so that
coronary venous PO2 was maintained. Selective KATP
1 channel
blockade with glibenclamide (3 mg/kg iv), decreased SVC by
29 6 4% at rest and by 10 6 2% at 5 km/h (both P , 0.05),
whereas PVC was unchanged. Glibenclamide decreased cor-
onary vascular conductance and hence myocardial O2 deliv-
ery, necessitating an increase in O2 extraction from 76 6 2%
to 86 6 2% at rest and from 79 6 2% to 83 6 1% at 5 km/h.
Consequently, coronary venous PO2 decreased from 25 6 1 to
17 6 1 mmHg at rest and from 23 6 1 to 20 6 1 mmHg at 5
km/h (all values are P , 0.05). In conclusion, KATP
1 channels
dilate the systemic and coronary, but not the pulmonary,
resistance vessels at rest and during exercise in swine. How-
ever, opening of KATP
1 channels is not mandatory for the
exercise-induced systemic and coronary vasodilation.
exercise; coronary circulation; pulmonary circulation; sys-
temic circulation
OVER A DECADE AGO, hyperpolarization of the vascular
smooth muscle cell membrane caused by opening of ATP-
sensitive K1 (KATP
1 ) channels was discovered as a novel
mechanism of vasodilation. Subsequently, the pharmaco-
logical openers of these KATP
1 channels have been shown
to dilate resistance vessels in the systemic (20, 27), pul-
monary (13, 20, 24, 28), and coronary (9, 27) vascular
beds. Additionally, blockade of KATP
1 channels increases
basal tone in the systemic (5, 11, 17, 21, 23, 33), pulmo-
nary (20, 24), and coronary circulations (9, 15), indicating
that these channels contribute significantly to the regu-
lation of basal vasomotor tone in these vascular beds. In
contrast, information on the role of KATP
1 channels in the
adaptation of vasomotor tone during increased metabolic
demands produced by exercise is limited. Thus only two
studies (9, 10) on dogs reported the role of KATP
1 channels
in exercise-induced coronary vasodilation, whereas no
study investigated the role of KATP
1 channels in the adap-
tation of vasomotor tone in the pulmonary and regional
systemic vascular beds during exercise. Consequently, in
the present study we investigated the role of KATP
1 chan-
nels in the regulation of systemic, pulmonary, and coro-
nary vasomotor tone in awake pigs under basal resting
conditions and during treadmill exercise, resulting in
heart rates up to 85% of the maximum heart rate.
MATERIALS AND METHODS
Crossbred Landrace 3 Yorkshire pigs were used in the
present study. All of the experiments were performed in
accordance with the Guide for the Care and Use of Laboratory
Animals as approved by the Council of the American Physi-
ological Society and the regulations of the Animal Care
Committee of the Erasmus University Rotterdam (The Neth-
erlands). Adaptation of animals to the laboratory conditions
started 1 wk before the day of surgery and continued until 10
days postoperatively. Full details of the experimental proce-
dures have been published previously (7, 8, 27, 30).
Surgical Procedures
After an overnight fast, 11 pigs (6 male and 5 female,
weighing 24 6 1 kg at the time of surgery and 29 6 1 kg at
the time of study) were sedated with ketamine (20 mg/kg im;
Ketalin, Apharmo, Arnhem, The Netherlands), anesthetized
with 10 mg/kg iv thiopental sodium (Rhone-Rorer-Poulenc,
Amstelveen, The Netherlands), and intubated and mechani-
cally ventilated with a mixture of O2 and nitrous oxide (1:2),
to which 0.2–1.0% vol/vol isoflurane (Forene, Abbott, Am-
stelveen, The Netherlands) was added. Anesthesia was fur-
ther maintained with midazolam (2 mg/kg 1 1 mg zkg21 zh21
iv; Dormicum, Roche, Mijdrecht, The Netherlands) and fen-
tanyl (10 mg zkg21 zh21 iv; Janssen-Cilag, Tilburg, The Neth-
erlands). Under sterile conditions, the chest was opened via
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the fourth left intercostal space and an 8-Fr fluid-filled poly-
vinyl chloride catheter was inserted into the aortic arch for
the measurement of central aortic blood pressure and collec-
tion of arterial blood samples and secured with a purse-string
suture. After the pericardium was opened, an electromag-
netic flow probe (14–15 mm inner diameter) was positioned
around the ascending aorta for the measurement of ascend-
ing aortic blood flow (Transflow 601 Systems, Skalar, Delft,
The Netherlands). A high-fidelity pressure transducer (model
P4.5, Konigsberg Instruments, Pasadena, CA) was inserted
into the left ventricle via the apical dimple for recording of
left ventricular (LV) pressure and the maximum of its first
derivative (LV dP/dtmax). An 8-Fr catheter was inserted into
the left ventricle for calibration of the Konigsberg transducer
signal. An 8-Fr catheter was also inserted into the pulmonary
artery for measurement of pulmonary artery pressure, with-
drawal of mixed venous blood samples, and administration of
drugs, and another 8-Fr catheter was inserted into the left
atrial appendage for measurement of left atrial pressure and
injection of radioactive microspheres to determine regional
organ and tissue blood flows (27). For the measurement of
coronary blood flow, a Doppler flow probe of 2.0–3.0 mm
inner diameter, emitting frequency (F0) 5 10 MHz, was
placed around the proximal part of the left anterior descend-
ing (LAD) coronary artery (model HVPD-10, Crystal Biotech,
Northboro, MA) for measurement of coronary blood flow (7, 8,
16). A small angiocatheter (0.8/1.1 mm, inner/outer diame-
ter) connected to a larger Tygon catheter (0.8/2.4 mm, inner/
outer diameter) was inserted directly into the anterior inter-
ventricular vein to allow sampling of coronary venous blood.
Electrical wires and catheters were tunneled subcutaneously
to the back, the chest was closed, and the animals were
allowed to recover. All of the electrical wires and catheters
were protected with a vest.
Postsurgical period. After surgery, the animals received
analgesia by daily intramuscular injections of 0.3 mg bu-
prenorphine (Temgesic; Schering-Plough, Amstelveen, The
Netherlands) during the first 48 h and intravenous injections
of 25 mg/kg amoxicillin (Clamoxyl, Beecham Farma, Am-
stelveen, The Netherlands) and 5 mg/kg gentamycin (AUV,
Cuijk, The Netherlands) on a daily basis during the first
week to prevent infections. The catheters were flushed daily
with physiological saline containing 2,000 U/ml heparin so-
dium (Leo Pharmaceutical Products, Weesp, The Nether-
lands).
Experimental Protocols
Studies were performed 10–20 days after surgery with
animals either resting in a cage or exercising on a motor-
driven treadmill.
Degree, duration, and selectivity of KATP
1 channel blockade
produced by glibenclamide. To determine the degree and
duration of KATP
1 channel blockade produced by gliben-
clamide, studies were performed in five awake resting pigs.
After animals had been lying quietly for 15 min, baseline
measurements were collected and the effects of four con-
secutive intravenous infusions (37.5, 75, 150, and 225
mg zkg21 zmin21) of the KATP
1 channel opener bimakalim (27)
on heart rate, mean aortic blood pressure, cardiac output,
and coronary blood flow were studied.
On a different day, baseline hemodynamic measurements
were recorded and blood samples were collected, after which
animals received an intravenous infusion of glibenclamide (3
mg/kg in 20 ml, administered over 5 min). Five minutes after
administration was completed, measurements were made at
3-min intervals over a 12-min period corresponding to the
total exercise protocol period (see Experimental Protocols).
After we completed these measurements, four consecutive
infusions of bimakalim (37.5, 75, 150, and 225 mg zkg21 z
min21) were administered.
To confirm the reported (9, 10) specificity of glibenclamide,
six consecutive, 5-min infusions of sodium nitroprusside (0.5,
1, 2, 3, 4, and 5 mg zkg21 zmin21) were administered intrave-
nously before and 5 min after glibenclamide (3 mg/kg iv) in
two awake but resting pigs.
Exercise Protocols
Two exercise protocols were performed on different days
and in random order. The aim of the first protocol was to
study the effect of KATP
1 channel blockade during exercise. In
the second protocol we confirmed the reproducibility of two
consecutive exercise tests performed at a 90-min interval (7,
8, 30).
KATP
1 channel blockade. With the pigs resting quietly on
the treadmill, resting hemodynamic measurements were ob-
tained, and arterial, mixed venous, and coronary venous
blood samples were collected (7, 8). After all of the hemody-
namic measurements were repeated and rectal temperature
was measured with animals standing on the treadmill, a
five-stage treadmill exercise protocol was started (1–5 km/h).
Each exercise stage lasted 2–3 min. Hemodynamic variables
were continuously recorded and blood samples collected dur-
ing the last 45 s of each exercise stage, at a time when
hemodynamics had reached a steady state. After completing
the exercise protocol, the animals were allowed to rest on the
treadmill. Ninety minutes later, the animals received an
intravenous infusion of glibenclamide (3 mg/kg in 20 ml,
administered over 5 min) to produce KATP
1 channel blockade.
Five minutes after completion of the glibenclamide infusion,
resting measurements were obtained, and the exercise pro-
tocol was repeated. To prevent glibenclamide-induced de-
creases in blood glucose levels, the animals received intrave-
nous 10-ml 10% glucose injections at rest and after collection
of measurements at 2 and 4 km/h.
On a different day, the effects of KATP
1 channel blockade on
regional organ and tissue blood flows were studied in five
pigs. For this purpose, radioactive microspheres were in-
jected in pigs when resting quietly on the treadmill and when
exercising at 5 km/h before and after 90 min of rest, in the
presence of glibenclamide (3 mg/kg iv).
Reproducibility of responses to exercise. Ninety minutes
after the pigs had undergone a control exercise period, the
animals received 20 ml of physiological saline, after which
resting measurements were obtained and the five-stage ex-
ercise protocol was repeated.
Blood Gas and Glucose Measurements
Blood samples were maintained in ice-cold syringes until
the conclusion of each exercise trial. Measurements of PO2
(mmHg), PCO2 (mmHg), pH, and standard base excess (SBE)
were then immediately performed with a blood gas analyzer
(Acid-Base Laboratory model 505, Radiometer, Copenhagen,
Denmark). O2 saturation (SO2) and hemoglobin (Hb, 100
ml/g) were measured with a hemoximeter (OSM2, Radiome-
ter). Arterial glucose measurements were performed with the
use of Glucostix (Bayer Diagnostics, Mijdrecht, The Nether-
lands) and a glucometer (model 5626, Miles).
Data Acquisition and Analysis
All hemodynamic data were recorded and digitized on-line
by using an eight-channel data-acquisition program ATCO-
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DAS (Dataq Instruments, Akron, OH) and stored on a com-
puter for off-line analysis with a program written in MatLab
(Mathworks, Natick, MA). A minimum of 15 consecutive
beats were selected for analysis of the digitized hemodynamic
signals.
Cardiac output was computed as the sum of ascending
aortic blood flow (measured with an electromagnetic flow
probe) and total coronary blood flow. Because the LAD coro-
nary artery supplies ;40% of the left ventricle, total coronary
blood flow was taken as 2.53 flow in the LAD coronary
artery. Systemic and coronary vascular conductance were
calculated as the ratio of cardiac output and mean aortic
pressure and coronary blood flow and mean aortic pressure,
respectively. Blood O2 content (mmol/ml) was computed as
[0.621 zHb (g%) zO2 saturation (%)] 1 [0.00131 zPO2 (mmHg)].
Myocardial O2 delivery (MDO2) in the LAD coronary artery
perfused area was computed as the product of arterial O2
content and LAD coronary blood flow; whole body O2 delivery
(BDO2) was calculated as the product of arterial O2 content
and cardiac output. MVO2 in the region perfused by the LAD
coronary artery was calculated as the product of coronary
blood flow and the difference in O2 content between arterial
and coronary venous blood; whole body O2 consumption
(BVO2) was calculated as the product of cardiac output and
difference in O2 content between arterial and mixed venous
blood. Myocardial O2 extraction was computed as the ratio of
arteriocoronary venous O2 content difference and the arterial
O2 content; whole body O2 extraction was calculated as the
ratio of the difference in the arterial and mixed venous O2
contents and the arterial O2 content.
Statistical analysis of the exercise and treatment data was
performed by using a two-way ANOVA for repeated mea-
sures. When a significant effect of exercise was observed, post
hoc testing was done by using Dunnett’s test. When a signif-
icant effect of treatment was observed, post hoc testing was
done with the use of either a paired Student’s t-test or
Wilcoxon signed rank test. A two-tailed P value of ,0.05 was
considered statistically significant. All data are presented as
means 6 SE.
Drugs
Glibenclamide (Sigma-Aldrich, Bornem, Belgium) was dis-
solved in 20-ml distilled water (30°C, pH 8–9), whereas
bimakalim (courtesy of P. Schelling; Merck, Darmstadt,
Germany) was dissolved in 30°C saline to produce a concen-
tration of 100 mg zkg21 zml21. Sodium nitroprusside (25 mg/
ml) (Department of Pharmacy, Academic Hospital Dijkzigt,
Rotterdam, The Netherlands) was diluted in 37°C saline to
produce a concentration of 1 mg zkg21 zml21. Fresh drug so-
lutions were prepared daily.
RESULTS
Degree, Stability, and Selectivity of KATP
1 Channel
Blockade Produced by Glibenclamide
Bimakalim produced a dose-dependent increase in
systemic and coronary vascular conductance (Fig. 1)
and a small increase in pulmonary vascular conduc-
tance from 0.29 6 0.04 l zmin21 zmmHg21 at baseline
up to 0.33 6 0.06 l zmin21 zmmHg21 (P , 0.05) during
the highest dose of bimakalin (225 mg zkg21 zmin21).
Twenty minutes after administration of glibenclamide
(3 mg/kg iv), the bimakalim-induced vasodilation was
blunted by 60–70%, whereas the vasodilation produced
by sodium nitroprusside remained unmitigated (Fig.
1). Glibenclamide resulted in stable decreases in mixed
venous and coronary venous SO2 saturation over the
12-min period (Fig. 2). These data indicate that glib-
enclamide produced a good and stable degree of selec-
tive blockade of KATP
1 channels over a time period
corresponding with the total exercise trial period (12 6
1 min).
Fig. 1. Effect of glibenclamide (Glib, 3 mg/kg iv, n 5 5 pigs) on
bimakalim-induced (left) and sodium nitroprusside (right)-induced
increases in systemic vascular conductance (SVC, top) and coronary
vascular conductance (CVC, bottom). Note that the increase in con-
ductance by bimakalim was significantly (P , 0.01) attenuated by
Glib, whereas the increase in conductance by nitroprusside was
unaffected. Data are means 6 SE.
Fig. 2. Stability of Glib-induced (3 mg/kg iv) decreases in mixed
venous and coronary venous O2 saturations. Data are means 6 SE;
n 5 3 pigs.
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Effects of KATP
1 Channel Blockade During Exercise
Systemic circulation. Exercise produced an increase
in cardiac output from 4.0 6 0.2 l/min at rest (lying
down) to 8.3 6 0.3 l/min at 5 km/h (P , 0.01), which
was principally due to an increase in heart rate from
121 6 5 to 245 6 8 beats/min (P , 0.01, ;85% of
maximum heart rate) as stroke volume increased
,10% (Table 1). Because LV systolic pressure in-
creased from 110 6 2 mmHg at rest to 136 6 3 mmHg
at 5 km/h, P , 0.01, the maintained stroke volume was
the result of an increase in left atrial pressure from 4 6
1 to 14 6 3 mmHg (P , 0.01) and an increase in LV
dP/dtmax from 2,940 6 120 to 5,890 6 180 mmHg/s (P ,
0.01). Mean aortic pressure decreased slightly when
the animals went from a lying position to a standing
position but did not change during exercise. The main-
tained mean aortic blood pressure in the presence of a
doubling of cardiac output implies a doubling of sys-
temic vascular conductance.
Exercise resulted in a decrease in arterial PCO2 from
44 6 1 mmHg at rest to 39 6 1 mmHg at 5 km/h and an
increase in arterial pH from 7.44 6 0.01 to 7.47 6 0.01
(both P , 0.05) (Table 2). Arterial PO2 and SO2 (97 6 1%
at rest and 96 6 1% at 5 km/h) did not change from
their baseline values, but Hb and O2 content increased
by 15 6 4% and 14 6 4% at the highest level of exercise
compared with resting conditions (both P , 0.05).
Mixed venous PO2 (Table 2), SO2, and O2 content (not
shown) decreased progressively during exercise,
whereas mixed venous PCO2 and pH were minimally
Table 1. Effect of KATP
1 channel blockade on hemodynamic responses to graded treadmill exercise
Rest Treadmill Exercise, km/h
Lying Standing 1 2 3 4 5
Systemic hemodynamics
CO, l/min
Control 4.060.2 5.360.3* 6.160.2* 6.760.2* 7.260.2* 7.860.3* 8.360.3*
Glib 3.460.2† 4.460.2*† 5.560.2*† 6.160.2*† 6.860.3*† 7.660.3* 8.160.3*
HR, beats/min
Control 12165 14769* 17368* 19669* 21369* 235610* 24568*
Glib 10065† 11564*† 14266*† 16066*† 18067*† 207611*† 225611*†
SV, ml
Control 33.161.0 36.161.2* 35.561.2* 34.361.1 34.260.8 33.361.0 33.860.9
Glib 34.160.7 38.460.8* 38.861.1*† 38.360.6*† 38.060.9*† 37.061.4*† 36.461.4*†
LVSP, mmHg
Control 11062 11562* 11963* 12363* 12463* 13163* 13663*
Glib 12764† 12664† 12362 12562 12662 13063 13463*
LV dP/dtmax, mmHg/s
Control 2,9406120 3,7006240* 4,2306250* 4,7206180* 4,9306140* 5,5106180* 5,8906180*
Glib 2,600670† 2,890680*† 3,5306150*† 3,8906180*† 4,3006150*† 4,8506150*† 5,4506210*†
MAP, mmHg
Control 9662 9262* 9063* 9163* 9063* 9163* 9263*
Glib 11662† 11162† 10463*† 10463*† 10262*† 10063*† 10063*†
SVC, ml zmin21 zmmHg21
Control 4262 5863* 6964* 7463* 8163* 8764* 9165*
Glib 2962† 4062*† 5363*† 5963*† 6863*† 7663*† 8163*†
Pulmonary hemodynamics
MPAP, mmHg
Control 1661 1662 1961 2362* 2762* 3162* 3462*
Glib 1761 1762 2061 2262* 2762* 3162* 3362*
MLAP, mmHg
Control 461 161 261 462 762 1162* 1463*
Glib 761 562 561 662 962 1262* 1462*
PVC, 1 zmin21 zmmHg21
Control 0.3560.05 0.3560.03 0.3760.04 0.3760.03 0.3960.03 0.4060.04* 0.4260.05*
Glib 0.3160.03 0.3760.04 0.3760.04 0.3960.05* 0.4160.06* 0.4260.06* 0.4460.06*
Coronary hemodynamics
CBF, ml/min
Control 5064 7167* 8769* 94610* 100610* 113613* 118613*
Glib 4464† 5564*† 7165*† 7767*† 8667*† 102611*† 110612*†
CVC, ml zmin21 zmmHg21
Control 0.5360.04 0.7760.07* 0.9860.11* 1.0560.11* 1.1260.11* 1.2660.15* 1.3260.17*
Glib 0.3860.04† 0.4960.05*† 0.6960.06*† 0.7660.08*† 0.8660.07*† 1.0460.11*† 1.1260.12*†
Values are means 6 SE; n 5 9 pigs. CO, cardiac output; HR, heart rate; SV, stroke volume; LV dP/dtmax, maximum rate of rise of left
ventricular (LV) pressure; MAP, mean aortic pressure; LVSP, LV systolic pressure; SVC, systemic vascular conductance; MPAP, mean
pulmonary artery pressure; MLAP, mean left atrial pressure; PVC, pulmonary vascular conductance; CBF, coronary blood flow of the left
anterior descending (LAD) coronary artery perfused myocardium; CVC, coronary vascular conductance; Glib, glibenclamide, 3 mg/kg iv.
*P , 0.05 vs. Rest; †P , 0.05 vs. Control.
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Fig. 3. Effect of ATP-sensitive K1 (KATP
1 ) channel blockade with Glib (3 mg/kg iv, top) or an equivalent volume of
saline (bottom) on the relations between whole body O2 consumption (BVO2) and SVC, between BVO2 and body O2
delivery (BDO2; dashed line represents line of identity), between BVO2 and body O2 extraction, and between BVO2
and mixed venous PO2. Data points were obtained at rest (lying) and during 5 levels of treadmill exercise (1–5
km/h). Data are means 6 SE; n 5 9 pigs; *P , 0.05 vs. Control.
Table 2. Effect of KATP
1 channel blockade on blood gas responses to graded treadmill exercise
Rest (Lying)
Treadmill Exercise, km/h
1 2 3 4 5
Hb, g/100 ml
Control 7.060.4 7.560.4* 7.560.4* 7.760.4* 7.860.3* 8.060.3*
Glib 6.560.3 6.760.3 6.860.2 7.260.3* 7.560.3* 7.760.3*
Art pH
Control 7.4460.01 7.4460.01 7.4560.01 7.4560.01 7.4660.01* 7.4760.01*
Glib 7.4460.01 7.4460.01 7.4560.01 7.4660.01 7.4760.01* 7.4860.01*
Art PCO2, mmHg
Control 4461 4461 4361 4261 4061* 3961*
Glib 4361 4361 4161 4061* 3961* 3861*
Art PO2, mmHg
Control 10963 10664 10863 10563 10465 10364
Glib 11563 10562 11063 10865 10764 10665
MV pH
Control 7.3860.01 7.3760.01 7.3760.01 7.3760.01 7.3760.01 7.3760.01
Glib 7.3760.01 7.3560.01*† 7.3660.01 7.3560.01† 7.3560.01*† 7.3460.01*†
MV PCO2, mmHg
Control 5361 5361 5561 5561 5461 5561
Glib 5461 5561 5461 5561 5561 5661
MV PO2, mmHg
Control 4361 3561* 3361* 3161* 2961* 2661*
Glib 3761† 3161*† 3061*† 2861*† 2561*† 2361*†
CV pH
Control 7.3660.01 7.3760.01 7.3860.01 7.3760.01 7.3760.01 7.3760.01
Glib 7.3560.01† 7.3560.01† 7.3560.01† 7.3660.01* 7.3660.01* 7.3760.01*
CV PCO2, mmHg
Control 5761 5661 5661 5561 5462 5561
Glib 5961 5861 5661* 5661* 5461* 5361*†
CV PO2, mmHg
Control 2561 2561 2361 2460 2361 2361
Glib 1761† 1761† 1861† 1761† 1961† 2061*†
Values are means 6 SE; n 5 9 pigs. Hb, hemoglobin; Art, arterial; MV, mixed venous; CV, coronary venous; P, partial pressure; Glib,
3 mg/kg iv. *P , 0.05 vs. Rest (Lying); †P , 0.05 vs. Control.
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affected. Because both cardiac output and the differ-
ence in the arterial and mixed venous O2 contents
nearly doubled, BVO2 increased fourfold from 7.5 6 0.3
to 30.1 6 0.8 mmol/min, respectively (P , 0.01, Fig. 3).
Glibenclamide increased mean aortic blood pressure
that was the result of a decrease in systemic vascular
conductance as cardiac output decreased at rest and
lower levels of exercise or remained unchanged at 4
and 5 km/h (Table 1) due to a possibly baroreceptor
reflex-mediated decrease in heart rate. The decrease in
systemic vascular conductance was compensated by an
increase in O2 extraction, so that body O2 consumption
was maintained. Consequently, mixed venous PO2 and
O2 content were decreased at rest and during each
level of exercise (Table 2). The glibenclamide-induced
decrease in systemic vascular conductance and mixed
venous PO2 were similar at rest and all levels of exer-
cise, indicating that KATP
1 channel blockade did not
affect the exercise-induced systemic vasodilation (Fig.
3). The increased systemic vasomotor tone resulted in
an increased arterio-mixed venous pH difference,
which was principally due to an increase in arterio-
mixed venous PCO2 difference (not shown), suggesting
that the glibenclamide-induced vasoconstriction did
not result in anaerobic metabolism.
Regional blood flows. During exercise at 5 km/h, flow
to the various skeletal muscle groups increased (Fig.
4), varying from 5-fold in predominantly white fiber
muscle to 20-fold in predominantly red fiber muscle (1).
Brain flow increased by ;20% (P # 0.05), flow to the
adrenals and bone did not change, and flow to most
visceral organs decreased (Table 3). Arteriovenous
anastomotic (AVA) flow, represented by lung flow (27)
and cutaneous flow increased by 300% and 25%, re-
spectively.
Glibenclamide had no effect on skeletal muscle blood
flow, in any of various skeletal muscle groups indepen-
dent of fiber-type composition, either at rest or during
exercise (Fig. 4). In contrast, glibenclamide decreased
flow to most visceral organs at rest and/or during
exercise at 5 km/h (Table 3), whereas bone flow was not
affected. Glibenclamide also reduced skin flow but had
no effect on AVA flow. Vascular conductance in all
visceral organs, bone, and skin decreased at rest and/or
Fig. 4. Effect of KATP
1 channel blockade with Glib (3 mg/kg iv) on blood flow to various skeletal muscle groups of
the trunk (A), hind legs (B), and front legs (C). Data points were obtained at rest (lying) and during treadmill
exercise at 5 km/h. Glib had no significant effect on blood flow in any of the skeletal muscle groups either at rest
or during exercise. Data are means 6 SE; n 5 5 pigs.
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during exercise, but AVA conductance was not signifi-
cantly altered (Table 3). Glibenclamide had no effect on
the exercise-induced increases in vascular conductance
in skeletal muscle (not shown).
Pulmonary circulation. Exercise resulted in an in-
crease of mean pulmonary artery pressure from 16 6 1
to 34 6 2 mmHg (P , 0.01; Table 1). The driving
pressure across the pulmonary vascular bed (mean
pulmonary artery pressure-mean left atrial pressure)
increased slightly less than the increase in cardiac
output so that pulmonary vascular conductance in-
creased by 25 6 9% (P , 0.05) (Table 1 and Fig. 5).
Glibenclamide had no effect on pulmonary artery pres-
sure or pulmonary vascular conductance, either at rest
or during exercise.
Coronary circulation. Blood flow in the LAD coro-
nary artery increased from 50 6 4 ml/min at rest to
118 6 13 ml/min during the highest level of exercise
(P , 0.01). Exercise had no effect on coronary venous
PCO2, pH, PO2 (Table 2, Fig. 6), SO2, or O2 content (not
shown). MVO2 increased from 162 6 18 to 465 6 44
mmol/min, whereas MDO2 increased from 212 6 20 to
585 6 53 mmol/min, respectively (both P , 0.01). Con-
sequently, myocardial O2 extraction and coronary ve-
nous PO2 were minimally affected during exercise.
KATP
1 channel blockade with glibenclamide decreased
coronary blood flow and coronary vascular conduc-
tance, which resulted in a decrease in O2 delivery at
each level of MVO2 (P , 0.05), necessitating an increase
in O2 extraction, which led to a decrease in coronary
venous PO2 (Fig. 6). Similar to the systemic circulation,
the effect of glibenclamide on coronary vascular con-
ductance was also similar at rest and at each level of
exercise, indicating that KATP
1 channel blockade did not
modify the exercise-induced coronary vasodilation. The
increased coronary vasomotor tone resulted in an in-
creased arteriocoronary venous pH difference, due to
the widening of arteriocoronary venous PCO2 gradient
as the arteriocoronary venous SBE difference was un-
changed (not shown), indicating that the gliben-
clamide-induced flow reduction did not result in myo-
cardial ischemia.
Blood glucose. Blood glucose did not change during
control exercise (6.8 6 0.8 mmol/l at rest and 5.9 6 0.6
mmol/l at 5 km/h). With the glucose-supplementation
regimen, glucose levels after glibenclamide were simi-
Fig. 5. Effect of KATP
1 channel blockade
with Glib (3 mg/kg iv; left) or an equiva-
lent volume of saline (right) on the rela-
tion between BVO2 and pulmonary vascu-
lar conductance (PVC). Data points were
obtained at rest (lying) and during 5 levels
of treadmill exercise (1–5 km/h). Data are
means 6 SE; n 5 7 pigs; neither saline nor
Glib had a significant effect on the relation
between BVO2 and PVC.
Table 3. Effect of KATP
1 channel blockade on regional
blood flows and regional vascular conductances
Blood Flow,
ml zmin21 z100 g21
Conductance, ml zmin z100
g21 zmmHg21
Rest 5 km/h Rest 5 km/h
Total brain
Control 9665 11863* 1.0160.04 1.3660.06*
Glib 10068 119610 0.8860.07† 1.2560.11†
Kidneys
Control 370618 350632 3.9360.24 4.0260.37
Glib 311614† 306617† 2.7260.15† 3.2260.21†
Urine bladder
Control 10.061.0 11.161.7 0.10760.012 0.12760.019
Glib 10.061.4 9.562.1 0.08760.011† 0.09960.022†
Adrenals
Control 182619 202624 1.9360.19 2.3260.29*
Glib 120611† 163619† 1.0560.12† 1.7060.19*†
Spleen
Control 182627 47614* 1.9360.28 0.5660.19*
Glib 103621† 2468*† 0.9060.18† 0.2660.09*†
Pancreas
Control 186616 104612* 1.9860.20 1.2160.16*
Glib 91613† 6567*† 0.8060.13† 0.6960.09†
Stomach
Control 161615 122614* 1.7160.16 1.3960.15*
Glib 6266† 6369† 0.5560.06† 0.6660.10†
Ileum
Control 200653 143632* 2.1260.56 1.6060.33
Glib 128631† 102619† 1.1060.25† 1.0560.17†
Colon
Control 98612 5963* 1.0460.14 0.6860.03*
Glib 6968† 64612 0.6060.07† 0.6460.12
Bone
Control 15.661.5 15.461.3 0.16660.017 0.17860.018
Glib 13.160.9 13.361.6 0.11460.006† 0.13860.015†
Skin
Control 7.461.1 9.261.3* 0.07960.013 0.10660.016*
Glib 3.860.5† 6.061.5*† 0.03360.004† 0.06260.016*†
Lungs, AVA
Control 5769 222644* 0.6160.10 2.6360.61*
Glib 62611 197626* 0.5560.11 2.0860.32*
Values are means 6 SE; n 5 5 pigs. AVA, arteriovenous anasto-
moses. *P , 0.05 vs. Rest, †P , 0.05 vs. Control.
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lar to levels during control conditions (7.1 6 0.6 mmol/l
at rest and 6.0 6 0.6 mmol/l at 5 km/h).
Reproducibility of Responses to Exercise
Ninety minutes after the control exercise period, at a
time when all hemodynamic variables had returned to
baseline resting values, the second period of exercise
resulted in almost identical responses to exercise (Ta-
bles 4 and 5, and Figs. 3, 5, and 6), with the exception
of heart rate and LV dP/dtmax, which were slightly
(,10%) lower during exercise at 2–5 km/h compared
with the first run (Table 4).
DISCUSSION
The present study describes the role of KATP
1 chan-
nels in the regulation of coronary, pulmonary, and
systemic vasomotor tone in awake pigs at rest and
during treadmill exercise. There are three major find-
ings in the present study. First, KATP
1 channel blockade
resulted in a decrease in systemic vascular conduc-
tance and regional vascular conductances within the
systemic bed at rest and during exercise, which was
associated with an increase in body O2 extraction and
decreased mixed venous PO2. However, the exercise-
induced increase in systemic vascular conductance,
which occurred principally in skeletal muscle, was
not affected. Second, KATP
1 channel blockade had no
effect on pulmonary vascular conductance either at
rest or during exercise. Third, KATP
1 channel block-
ade resulted in an increased myocardial O2 extrac-
tion and a decreased coronary venous PO2 under
resting conditions and during exercise indicating
that KATP
1 channels exerted a vasodilator influence
that contributed to maintaining MDO2 commensu-
rate with O2 demands. However, KATP
1 channels were
not mandatory for the exercise-induced coronary va-
sodilation. The implications of these findings will be
discussed in detail.
Methodological Considerations
Glibenclamide has been reported to be a selective
KATP
1 channel blocker at concentrations up to 5 mM (2,
26). In the present study we used a dose of 3 mg/kg iv.
In 30-kg pigs, this dose corresponds to 90 mg in ;2
liters of circulating blood volume, i.e., 90 mmol/l (Mw 5
494). However, 98–99% of glibenclamide is bound to
plasma proteins (12), so that the concentration of free
glibenclamide is in the range of 1–2 mM. These concen-
trations are well within the range where glibenclamide
is selective for KATP
1 channels (2, 26). Moreover, we
observed that glibenclamide attenuated the bi-
makalim-mediated vasodilation without blunting the
sodium nitroprusside-mediated vasodilation, indicat-
ing that glibenclamide in a dose of 3 mg/kg iv selec-
tively inhibited KATP
1 channels without nonspecifically
blunting vascular smooth muscle relaxation.
Systemic Circulation
KATP
1 channels have been implicated in the regula-
tion of vasomotor tone under basal resting conditions
Fig. 6. Effect of KATP
1 channel blockade with Glib (3 mg/kg iv, top) or an equivalent volume of saline (bottom) on
the relations between myocardial VO2 consumption (MVO2) and CVC; between MVO2 and myocardial O2 delivery
(MDO2) (dashed line represents line of identity); between MVO2 and myocardial O2 extraction; and between MVO2
and coronary venous PO2. Data points were obtained at rest and during 5 levels of treadmill exercise. Data are
means 6 SE; n 5 8 pigs; *P , 0.05 vs. control.
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in a variety of regional vascular beds within the sys-
temic circulation including the mesenteric (11, 21),
renal (11, 23), and skeletal muscle bed (5, 11, 17, 33),
although the latter is not a ubiquitous finding (6, 19,
20, 31, 32). In the present study, we observed that in
awake resting pigs, KATP
1 channel activity exerts a
vasodilator influence in the brain, a variety of visceral
organs as well as bone and skin. In contrast, KATP
1
channel blockade had no effect on blood flow and vas-
cular conductance of various skeletal muscle groups,
indicating a minimal contribution of KATP
1 channels to
the regulation of basal vasomotor tone in resistance
vessels of skeletal muscle.
KATP
1 channel blockade also decreased systemic vascu-
lar conductance during treadmill exercise but did not
blunt the exercise-induced doubling of systemic vascu-
lar conductance. The latter is principally due to an
increase in vascular conductance in active skeletal
muscle groups and to a lesser extent to increases in
cerebral, AVA, and cutaneous vascular conductance (1,
18, and present study). Recent studies in anesthetized
animal models suggest that KATP
1 channels can contrib-
ute to metabolic vasodilation in skeletal muscle pro-
duced by electrical muscle stimulation (3, 5, 31, 33).
Although the vasoconstrictor effect of KATP
1 channel
blockade in the present study persisted during tread-
mill exercise, indicating that KATP
1 channels exert a
vasodilator influence at rest and during exercise, KATP
1
channel blockade had no effect on the increase in vas-
cular conductance in the brain, skeletal muscle, skin,
and of AVA. These findings demonstrate that the open-
ing of KATP
1 channels is not mandatory for the exercise-
induced vasodilation in these regional beds. It is pos-
sible that under normal conditions opening of these
channels does contribute but that after KATP
1 channel
blockade other vasodilator mechanisms are recruited
Table 4. Reproducibility of hemodynamic responses to graded treadmill exercise
Rest Treadmill Exercise, km/h
Lying Standing 1 2 3 4 5
Systemic hemodynamics
CO, l/min
Control 3.860.2 5.160.3* 5.760.2* 6.560.2* 7.260.2* 7.960.4* 8.460.4*
Saline 3.960.2 5.060.3* 5.960.3* 6.560.3* 7.260.3* 7.860.3* 8.360.4*
HR, beats/min
Control 12066 14365* 17266* 19265* 22066* 23967* 25366*
Saline 11765 14168* 16866* 18067*† 21067*† 23268* 25068*
SV, ml
Control 31.861.4 35.761.8* 33.261.3 34.261.3* 32.860.8 33.061.0 33.361.1
Saline 33.261.2 35.160.8* 35.361.0*† 35.961.0* 34.261.1 33.661.2 33.461.2
LVSP, mmHg
Control 11263 11463 11763 12464* 12564* 13264* 13765*
Saline 11364 11564 12066* 12065* 12365* 13065* 13566*
LV dP/dtmax, mmHg/s
Control 3,0806190 3,8006240* 4,2006240* 4,7806250* 5,2506270* 5,7306270* 6,2106320*
Saline 3,0206200 3,6606240* 4,2106240* 4,3106240*† 4,8706190*† 5,3606190*† 5,7506210*†
MAP, mmHg
Control 9862 9163* 8962* 9262* 9262* 9162* 9362*
Saline 9763 9062* 9162* 8862* 8861* 9062* 9062*
SVC, ml zmin21 zmmHg21
Control 3962 5764* 6463* 7163* 7963* 8765* 9265*
Saline 4163 5664* 6664* 7364* 8264* 8764* 9265*
Pulmonary hemodynamics
MPAP, mmHg
Control 1661 1361 1761 2161* 2762* 3061* 3461*
Saline 1561 1761 2061* 2161* 2662* 3161* 3461*
MLAP, mmHg
Control 461 2161* 161* 362 762 1061* 1261*
Saline 461 162* 261 461 662 1061* 1361*
PVC, l zmin21 zmmHg21
Control 0.3460.04 0.3860.04 0.3760.03 0.3960.03 0.3960.03 0.4260.05* 0.4460.05*
Saline 0.3560.04 0.3360.04 0.3460.03 0.3760.03 0.4060.04* 0.4360.06* 0.4560.07*
Coronary hemodynamics
CBF, ml/min
Control 5264 6867* 7667* 8869* 99613* 106615* 112617*
Saline 4966 6568* 8069* 84612* 96614* 107617* 109617*
CVC, ml zmin21 zmmHg21
Control 0.5360.05 0.7560.07* 0.8560.08* 0.9760.10* 1.0960.14* 1.1760.17* 1.2260.20*
Saline 0.5060.06 0.7260.10* 0.8660.11* 0.9460.13* 1.0860.16* 1.1760.19* 1.2160.21*
Values are means 6 SE; n 5 9 pigs for systemic hemodynamics; n 5 7 pigs for pulmonary and coronary hemodynamics. *P , 0.05 vs.
Rest; †P , 0.05 vs. Control.
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during exercise, which compensate for the loss of KATP
1
channel activity (10).
The decrease in systemic vascular conductance pro-
duced by glibenclamide impeded O2 delivery within the
systemic bed necessitating an increase in whole body
O2 extraction to maintain BVO2, reflected in the de-
crease in mixed venous PO2. The impediment of O2
delivery was associated with a widening of the arterio-
mixed venous pH gap, which could be interpreted to
suggest anaerobic metabolism. However, the increased
pH difference was principally due to a widening of the
arterio-mixed venous PCO2 difference. The latter prob-
ably resulted from a maintained whole body CO2 pro-
duction in the face of a reduced cardiac output.
Pulmonary Circulation
Evidence for KATP
1 channels in the pulmonary vascu-
lar bed has been obtained in a variety of species such as
rats (13), cats (20), pigs (24, and present study), and
dogs (28) by demonstrating pulmonary vasodilator re-
sponses to KATP
1 channel agonists in vivo. However,
under basal conditions, KATP
1 channel activity appears
to contribute minimally to regulation of vasomotor tone
in the intact lung of anesthetized rats (13) and cats (6).
Only in anesthetized newborn piglets was a decrease in
pulmonary vascular conductance observed after expo-
sure of a lung lobar arterial system to 10 mM of glib-
enclamide (24). However, glibenclamide at a dose
higher than 5 mM may produce blockade of other K1
channels (14, 26), including Ca21-sensitive channels,
which are abundantly present in the pulmonary bed
and active under basal conditions (13). This may also
explain why Kadowitz and co-workers (6, 20) observed
that glibenclamide, in a dose of 20 mg/kg but not at 5
mg/kg, produced a transient increase in pulmonary
artery pressure in anesthetized cats. Thus 20 mg/kg in
a 3-kg cat with an approximate blood volume of 300 ml
corresponds to a concentration of free glibenclamide of
8 mM, whereas 5 mg/kg corresponds to 2 mM. Another
concern is that in most previous in vivo studies anes-
thesia was employed, which can produce KATP
1 channel
blockade (28). However, because in awake dogs gliben-
clamide (3 mg/kg iv) had no effect on pulmonary vas-
cular conductance (28), and in the present study, gli-
benclamide (3 mg/kg iv, a dose that produced a sys-
temic vasoconstrictor response) had also no effect on
pulmonary vascular conductance, the weight of evi-
dence suggests that KATP
1 channel activity is minimal
under basal conditions in the pulmonary vascular bed.
The present study is the first to investigate the
role of KATP
1 channel activity in regulation of pul-
monary vascular conductance during exercise. The
rationale for this investigation was that we previ-
ously observed that b-adrenoceptor activation con-
tributes to exercise-induced pulmonary vasodilation
in pigs (30). Because pharmacological b-adrenocep-
Table 5. Reproducibility of blood gas responses to graded treadmill exercise
Rest (Lying)
Treadmill Exercise, km/h
1 2 3 4 5
Hb, g/100 ml
Control 7.660.3 7.560.3 8.060.3* 8.160.3* 8.160.3* 8.160.3*
Saline 7.560.2 7.860.2* 7.960.2* 8.160.2* 8.160.2* 8.360.2*
Art pH
Control 7.4460.01 7.4760.01* 7.4760.01* 7.4760.01* 7.4760.01* 7.4760.01*
Saline 7.4560.01 7.4560.01 7.4660.01 7.4860.01* 7.4860.01* 7.4960.01*
Art PCO2, mmHg
Control 4462 4261* 4261* 4161* 4161* 4061*
Saline 4461 4361 4261 4161* 3961* 3861*
Art PO2, mmHg
Control 10362 10762 10562 10663 10463 10763
Saline 10062 10263 10462 10663 10262 10563
MV pH
Control 7.3960.01 7.3960.01 7.3960.01 7.3860.01 7.3860.01 7.3660.01*
Saline 7.3960.01 7.3960.01 7.3960.01 7.3960.01 7.3960.01 7.3860.01
MV PCO2, mmHg
Control 5361 5461 5461 5661* 5661* 5861*
Saline 5361 5461 5461 5461 5361† 5461†
MV PO2, mmHg
Control 4161 3461* 3361* 3061* 2861* 2561*
Saline 4061 3461* 3361* 3161* 2761 2661*
CV pH
Control 7.3760.01 7.3960.01 7.3960.01 7.3860.01 7.3860.00 7.3860.01
Saline 7.3960.01 7.3860.01 7.3960.01 7.3960.01 7.3960.01 7.3860.01
CV PCO2, mmHg
Control 5962 5662 5762 5662 5661 5861
Saline 5662 5462 5462 5461 5461 5561
CV PO2, mmHg
Control 2561 2561 2561 2461 2461 2261
Saline 2561 2561 2561 2461 2461 2361
Values are means 6 SE; n 5 9 pigs. *P , 0.05 vs. Rest (lying); †P , 0.05 vs. Control.
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tor stimulation produces vasodilation in pulmonary
arteries (29), as well as other vascular beds (3, 22),
that is in part mediated by KATP
1 channel activation,
we hypothesized that the exercise-induced pulmo-
nary vasodilation could also be mediated via KATP
1
channel opening. However, the results clearly dem-
onstrate that KATP
1 channels are not mandatory for
maintaining pulmonary vascular conductance in
awake pigs either at rest or during treadmill exer-
cise.
Coronary Circulation
Coronary blood flow is tightly regulated to maintain
a consistently high level of myocardial O2 extraction.
Consequently, any increase in myocardial O2 demand
must be met by an equivalent increase in coronary
blood flow. In dogs the exercise-induced increase in
coronary blood flow does not fully match the increased
myocardial O2 demand, so that even during light exer-
cise (,60% of maximum heart rate) myocardial O2
extraction increases and coronary venous PO2 de-
creases (18). In humans, myocardial O2 extraction
changes minimally during light-to-moderate exercise,
but myocardial O2 extraction increases and coronary
venous PO2 decreases during strenuous exercise (.85%
of maximum heart rate) (18). Up to moderate exercise,
pigs resemble humans more closely than dogs but, in
contrast to dogs and humans, pigs also maintain a
constant level of myocardial O2 extraction and coro-
nary venous PO2 during strenuous exercise, implying
that the exercise-induced increases in O2 delivery
match the increases in MVO2 (7, 18). A decrease in
coronary venous PO2 could represent an error signal
needed for negative feedback metabolic control (18),
but data in pigs indicate that a decrease in coronary
venous PO2 is not mandatory for the increase in coro-
nary blood flow during heavy exercise due to increased
importance of b-adrenergic feedforward vasodilation
(7). In awake dogs, glibenclamide decreased coronary
blood flow at rest and during treadmill exercise but did
not blunt the exercise-induced increase in coronary
blood flow (9, 10). On the other hand, Narishige et al.
(22) reported that coronary vasodilation in the dog
heart that was produced by pharmacological b-adreno-
ceptor stimulation was markedly blunted by KATP
1
channel blockade. In view of the increased importance
of b-adrenergic feedforward vasodilation in the porcine
coronary circulation during exercise (7), we hypothe-
sized that b-adrenoceptor-mediated KATP
1 channel ac-
tivation would have increased importance in the coro-
nary circulation of exercising pigs. Although KATP
1
channel activity exerted a vasodilator influence both at
rest and during exercise, contrary to our hypothesis it
was not mandatory for the exercise-induced vasodila-
tion in the porcine heart. It is possible that under
normal conditions opening of these channels does con-
tribute but that after KATP
1 channel blockade other
vasodilator mechanisms are recruited during exercise,
which compensate for the loss of KATP
1 channel activity
(10).
The decrease in coronary vascular conductance pro-
duced by glibenclamide restricted MDO2 at each level of
MVO2, resulting in an increase in myocardial O2 ex-
traction and hence a decrease in coronary venous PO2.
The impediment of MDO2 was associated with a wid-
ening of the arteriocoronary venous pH gap, suggestive
of anaerobic metabolism (i.e., ischemia). However, the
increased pH difference was entirely the result of an
increased arteriocoronary venous PCO2 difference; the
latter likely resulted from a maintained CO2 produc-
tion in the face of reduced coronary arterial inflow.
In conclusion, the opening of KATP
1 channels contrib-
utes to a state of vasodilation in the systemic and
coronary circulation of pigs at rest and during exercise,
although KATP
1 channels are not mandatory for the
exercise-induced systemic and coronary vasodilation.
In contrast, KATP
1 channels are not mandatory for reg-
ulation of pulmonary vasomotor tone either at rest or
during exercise.
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